NCT06771622 2026-02-04
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
FBD Biologics Limited
Phase 1/2 Active not recruiting
FBD Biologics Limited
Suzhou Transcenta Therapeutics Co., Ltd.
University Health Network, Toronto
Thomas Jefferson University
Verastem, Inc.
Northwestern University
iOnctura